mTORC1–IRE1α Signaling in Palmitate Lipotoxicity
2026-08-29
This study identifies an mTORC1–IRE1α signaling axis that links palmitate metabolism to triglyceride overproduction and cell death in AML12 hepatocytes. Its inhibitor-based and metabolic perturbation strategy provides a mechanistic framework for studying saturated-fat-induced lipotoxicity and suggests that IRE1α, rather than ER stress as a broad endpoint alone, may be a tractable pathway for further investigation.
Pentoxifylline: From cAMP Biology to Skin Delivery
2026-08-29
Pentoxifylline is a phosphodiesterase inhibitor whose value in inflammation research depends on both cAMP biology and experimental delivery context. This guide connects cytokine assays with a validated niosome strategy for studying localized psoriasis responses.
Anlotinib Hydrochloride in Angiogenesis Research
2026-08-28
Anlotinib hydrochloride enables a multiparametric approach to angiogenesis research by combining endothelial migration, tube formation, receptor phosphorylation, and ERK readouts. This practical guide shows how to build robust assays, distinguish pathway inhibition from nonspecific toxicity, and extend findings toward translational cancer research.
MOB1A/B Loss Disrupts Intestinal Epithelial Homeostasis
2026-08-28
The reference study shows that intestinal epithelial MOB1A/B depletion simultaneously suppresses Wnt activity and activates BMP/TGF-β signaling, producing stem-cell loss, defective secretory differentiation, and progressive epithelial degeneration. Pharmacological inhibition partially restored differentiation but not the intestinal stem-cell pool, highlighting pathway cross-talk and the limits of single-pathway rescue.
Light-Inducible RNA Release for Gene Therapy Control
2026-08-27
The reference study introduces a rationally designed light-inducible RNA-releasing protein that controls mammalian gene expression at the translation stage. In mouse models, this optogenetic switch enabled light-dependent metabolic and retinal therapies, providing a framework for interruptible, on-demand gene therapy.
N3-kethoxal: Guanine-Selective Probe Workflows
2026-08-27
N3-kethoxal converts exposed guanine bases into click-ready nucleic acid landmarks for RNA structure studies, accessible-DNA mapping, and cellular interaction assays. This practical guide links probe chemistry to controlled workflows, quantitative pilot conditions, and troubleshooting strategies for separating genuine accessibility signals from handling artifacts.
Sulfonamides and hPON1: Evidence from Molecular Docking
2026-08-26
The 2017 study by Alim and colleagues evaluated six sulfonamides as inhibitors of purified human serum paraoxonase 1, distinguishing noncompetitive, mixed-type, and competitive inhibition. Its main contribution was to combine enzyme kinetics with molecular docking, while showing that Sulfisomidine, also known as sulfamethin, produced mixed-type inhibition rather than a simple active-site competitive mechanism.
S. eriocheiris Entry into Drosophila S2 Cells
2026-08-26
Wei and colleagues established a Drosophila Schneider 2 cell model showing that Spiroplasma eriocheiris invades insect cells through clathrin-mediated endocytosis and macropinocytosis. Pharmacological, cholesterol-disruption, and cytoskeletal experiments distinguish the entry routes and provide a useful framework for studying intracellular infection in an invertebrate system.
Adipose-Neural Axis in Cardiac Arrhythmia
2026-08-25
Fan et al. developed a stem cell-based coculture model showing how epicardial adipose tissue can communicate with sympathetic neurons and cardiomyocytes through a leptin–NPY/Y1R pathway. The study connects this signaling sequence to NCX and CaMKII activity and supports its clinical relevance through measurements in patients with atrial fibrillation.
AL-8810: Prostaglandin F2α Antagonist Workflow
2026-08-25
Use AL-8810 to separate FP receptor signaling from broader prostaglandin synthesis in endometrial, vascular, fibroblast, and smooth-muscle models. This workflow connects competitive receptor blockade with ERK1/2, MMP-2, VEGF-A, permeability, and tissue-remodeling readouts while emphasizing practical assay controls.
Berberrubine Suppresses RPE Chemokines via NF-κB
2026-08-24
The reference study showed that berberrubine reduces IL-8 and MCP-1 production in cytokine-stimulated ARPE-19 retinal pigment epithelial cells at both mRNA and protein levels. Its combination of ELISA, real-time PCR, and NF-κB localization analysis provides a focused cell-based framework for studying inflammatory chemokine regulation, while also highlighting the limits of inferring therapeutic activity from a single immortalized cell model.
LLC-PK1-MDR1 Model Improves BBB Permeability Prediction
2026-08-23
Hu et al. developed a high-throughput Transwell blood-brain barrier surrogate combining LLC-PK1-MOCK and LLC-PK1-MDR1 cells with a correction for lysosomal trapping. Across 41 compounds, the model linked in vitro permeability with unbound brain distribution and improved interpretation of compounds whose apparent transport was distorted by intracellular sequestration.
TaqI Restriction Endonuclease: Practical Protocol
2026-08-22
TaqI Restriction Endonuclease (SKU K3053) provides rapid, sequence-specific cleavage of plasmid DNA, PCR products, and genomic DNA when a TCG A recognition site is present. It is intended for research workflows such as restriction mapping and cloning, not for diagnostic, clinical, or medical use.
KPT330 and Cas9 Precision Editing
2026-08-21
The reference study identified selective inhibitors of nuclear export, including KPT330, as indirect regulators of Cas9, base-editing, and prime-editing activity. Its central contribution is the demonstration that controlling Cas9 mRNA nuclear export can improve editing specificity without directly inhibiting the Cas9 protein or DNA cleavage machinery.
Trichostatin A (TSA) in Breast Cancer Workflows
2026-08-20
Trichostatin A (TSA) provides a practical way to connect histone acetylation with proliferation, differentiation, and cell-cycle phenotypes in cancer models. This workflow emphasizes solvent control, phenotype-stratified assays, and careful interpretation when TSA is combined with CHK1- or chemotherapy-focused experiments.
460 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page